Publication | Open Access

Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival

Neuro-oncologyCerebral Vascular RegulationGliomaMedicineBlood-brain Barrier DisruptionBrain InjuryNeurologyHigh-grade GliomasNeurovascular DiseaseCerebral Blood FlowRecurrent GlioblastomaStrokeRadiation OncologyIntra-arterial DeliveryReperfusion InjuryHealth Sciences